Onyx Therapeutics, Inc. - Net Worth and Insider Trading

Onyx Therapeutics, Inc. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Onyx Therapeutics, Inc. owns 1 companies in total, including Kezar Life Sciences Inc (KZR) .

Click here to see the complete history of Onyx Therapeutics, Inc.’s form 4 insider trades.

Insider Ownership Summary of Onyx Therapeutics, Inc.

Ticker	Comapny	Transaction Date	Type of Owner
KZR	Kezar Life Sciences Inc	2018-06-20	10 percent owner

Onyx Therapeutics, Inc. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Onyx Therapeutics, Inc. Ownership Network

Ownership Network List of Onyx Therapeutics, Inc.

No Data

Ownership Network Relation of Onyx Therapeutics, Inc.

Onyx Therapeutics, Inc. Owned Company Details

What does Kezar Life Sciences Inc do?

Who are the key executives at Kezar Life Sciences Inc?

Onyx Therapeutics, Inc. is the 10 percent owner of Kezar Life Sciences Inc. Other key executives at Kezar Life Sciences Inc include 10 percent owner Morningside Venture Investments Ltd , Chief Business Officer Nicholas Michael Mordwinkin , and 10 percent owner Equal Talent Investments Ltd .

Kezar Life Sciences Inc (KZR) Insider Trades Summary

Over the past 18 months, Onyx Therapeutics, Inc. made no insider transaction in Kezar Life Sciences Inc (KZR). Other recent insider transactions involving Kezar Life Sciences Inc (KZR) include a net sale of 6,688 shares made by ,

In summary, during the past 3 months, insiders sold 0 shares of Kezar Life Sciences Inc (KZR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 669 shares of Kezar Life Sciences Inc (KZR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 669 shares.

Kezar Life Sciences Inc (KZR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Kezar Life Sciences Inc Insider Transactions

No Available Data

Onyx Therapeutics, Inc. Mailing Address

Above is the net worth, insider trading, and ownership report for Onyx Therapeutics, Inc.. You might contact Onyx Therapeutics, Inc. via mailing address: One Amgen Center Drive, Thousand Oaks Ca 91320-1799.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.